TRABIHealthcare Service Provider
Transgene Biotek Ltd — Balance Sheet
₹1.98
-2.15%
Transgene Biotek Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 7.58 Cr | 7.58 Cr | 7.58 Cr | 7.58 Cr | — |
| Share Issued | 7.58 Cr | 7.58 Cr | 7.58 Cr | 7.58 Cr | — |
| Net Debt | 14.24 Cr | 14.00 Cr | 13.11 Cr | 11.99 Cr | — |
| Total Debt | 14.52 Cr | 14.00 Cr | 13.11 Cr | 12.01 Cr | — |
| Tangible Book Value | 3.48 Cr | 4.16 Cr | 4.81 Cr | 5.96 Cr | — |
| Invested Capital | 24.55 Cr | 24.71 Cr | 24.48 Cr | 29.39 Cr | — |
| Working Capital | -11.47 Cr | -10.03 Cr | -9.42 Cr | -8.51 Cr | — |
| Net Tangible Assets | 3.48 Cr | 4.16 Cr | 4.81 Cr | 5.96 Cr | — |
| Common Stock Equity | 10.03 Cr | 10.71 Cr | 11.37 Cr | 17.38 Cr | — |
| Total Capitalization | 16.13 Cr | 15.79 Cr | 16.32 Cr | 22.15 Cr | — |
| Total Equity Gross Minority Interest | 10.03 Cr | 10.71 Cr | 11.37 Cr | 17.38 Cr | — |
| Stockholders Equity | 10.03 Cr | 10.71 Cr | 11.37 Cr | 17.38 Cr | — |
| Other Equity Interest | -65.74 Cr | 1.22 Cr | 1.23 Cr | 1.23 Cr | — |
| Capital Stock | 75.77 Cr | 75.77 Cr | 75.77 Cr | 75.77 Cr | — |
| Common Stock | 75.77 Cr | 75.77 Cr | 75.77 Cr | 75.77 Cr | — |
| Total Liabilities Net Minority Interest | 134.06 Cr | 131.62 Cr | 130.99 Cr | 129.72 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 121.32 Cr | 120.48 Cr | 120.52 Cr | 120.52 Cr | — |
| Other Non Current Liabilities | -1000.00 | 0.18 Cr | -1000.00 | 0.53 Cr | — |
| Non Current Deferred Taxes Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Long Term Debt And Capital Lease Obligation | 6.10 Cr | 5.08 Cr | 4.95 Cr | 4.77 Cr | — |
| Long Term Debt | 6.10 Cr | 5.08 Cr | 4.95 Cr | 4.77 Cr | — |
| Long Term Provisions | 115.22 Cr | 115.22 Cr | 115.22 Cr | 115.22 Cr | — |
| Current Liabilities | 12.74 Cr | 11.14 Cr | 10.47 Cr | 9.21 Cr | — |
| Other Current Liabilities | 1.27 Cr | 0.07 Cr | 0.10 Cr | 0.04 Cr | — |
| Current Debt And Capital Lease Obligation | 8.42 Cr | 8.92 Cr | 8.16 Cr | 7.24 Cr | — |
| Current Debt | 8.42 Cr | 8.92 Cr | 8.16 Cr | 7.24 Cr | — |
| Current Provisions | 1.35 Cr | 0.38 Cr | 1.82 Cr | 1.41 Cr | — |
| Payables | 1.59 Cr | 0.23 Cr | 0.28 Cr | 0.36 Cr | — |
| Total Tax Payable | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Accounts Payable | 1.59 Cr | 0.20 Cr | 0.23 Cr | 0.20 Cr | — |
| Total Assets | 144.09 Cr | 142.33 Cr | 142.36 Cr | 147.10 Cr | — |
| Total Non Current Assets | 142.83 Cr | 141.22 Cr | 141.31 Cr | 146.40 Cr | — |
| Other Non Current Assets | -1000.00 | -2000.00 | -3000.00 | 0.14 Cr | — |
| Non Current Deferred Taxes Assets | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other Investments | 0.10 Cr | 0.10 Cr | 0.10 Cr | — | — |
| Investmentin Financial Assets | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Investment Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Goodwill And Other Intangible Assets | 6.55 Cr | 6.55 Cr | 6.56 Cr | 11.42 Cr | — |
| Other Intangible Assets | 6.55 Cr | 6.55 Cr | 6.56 Cr | 11.42 Cr | — |
| Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net PPE | 3.29 Cr | 1.67 Cr | 1.76 Cr | 1.85 Cr | — |
| Gross PPE | 3.29 Cr | 14.52 Cr | 14.52 Cr | 14.52 Cr | — |
| Construction In Progress | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other Properties | 3.29 Cr | 1.05 Cr | 1.05 Cr | 1.05 Cr | — |
| Current Assets | 1.26 Cr | 1.11 Cr | 1.04 Cr | 0.70 Cr | — |
| Other Current Assets | 0.94 Cr | 1.06 Cr | 0.85 Cr | 0.58 Cr | — |
| Assets Held For Sale Current | 0.00 | 0.00 | 0.00 | — | — |
| Inventory | 0.03 Cr | 0.03 Cr | 0.03 Cr | 0.09 Cr | — |
| Taxes Receivable | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Accounts Receivable | 84000.00 | 84000.00 | 84000.00 | 84460.00 | — |
| Cash Cash Equivalents And Short Term Investments | 0.28 Cr | 77000.00 | 31000.00 | 0.02 Cr | — |
| Other Short Term Investments | 1000.00 | 66000.00 | 1000.00 | 56849.00 | — |
| Cash And Cash Equivalents | 0.28 Cr | 11000.00 | 30000.00 | 0.02 Cr | — |
| Cash Financial | 0.28 Cr | 11000.00 | 30000.00 | 0.02 Cr | — |
| Retained Earnings | — | -229.92 Cr | -229.26 Cr | -223.25 Cr | -200.81 Cr |
| Additional Paid In Capital | — | 146.06 Cr | 146.06 Cr | 146.06 Cr | 138.81 Cr |
| Non Current Deferred Revenue | — | 0.18 Cr | 0.35 Cr | 0.53 Cr | 0.70 Cr |
| Current Deferred Taxes Liabilities | — | 0.87 Cr | 0.87 Cr | — | 5.66 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 0.55 Cr | 0.54 Cr | — | — |
| Other Payable | — | 0.04 Cr | 0.05 Cr | 0.15 Cr | 0.20 Cr |
| Non Current Prepaid Assets | — | 132.90 Cr | 132.90 Cr | 133.04 Cr | 133.04 Cr |
| Long Term Equity Investment | — | 0.10 Cr | 0.10 Cr | 0.10 Cr | 0.00 |
| Investmentsin Associatesat Cost | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Investmentsin Subsidiariesat Cost | — | 0.10 Cr | 0.10 Cr | 0.10 Cr | 0.00 |
| Accumulated Depreciation | — | -12.85 Cr | -12.76 Cr | -12.67 Cr | -12.49 Cr |
| Machinery Furniture Equipment | — | 9.99 Cr | 9.99 Cr | 9.99 Cr | 9.99 Cr |
| Buildings And Improvements | — | 3.41 Cr | 3.41 Cr | 3.41 Cr | 3.41 Cr |
| Land And Improvements | — | 0.07 Cr | 0.07 Cr | 0.07 Cr | 0.07 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 1.06 Cr | 1.00 Cr | 0.58 Cr | 0.60 Cr |
| Raw Materials | — | 0.03 Cr | 0.03 Cr | 0.09 Cr | 0.02 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Transgene Biotek Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.